Klacid

Clarithromycin, the active ingredient in Klacid, is a macrolide antibiotic presented as an oral tablet for systemic use. It treats bacterial infections such as community‑acquired pneumonia, acute bacterial sinusitis, skin and soft‑tissue infections, and is used in combination regimens for Helicobacter pylori eradication. GNH USA supplies Klacid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Klacid, a macrolide antibiotic, is employed to treat bacterial infections in several organ systems.

Community‑acquired pneumonia: eradicates the causative bacteria and improves respiratory function. Acute bacterial sinusitis: reduces sinus inflammation and clears infection. Skin and soft‑tissue infections: combats staphylococcal and streptococcal pathogens. Helicobacter pylori eradication (in combination therapy): contributes to bacterial clearance as part of a multi‑drug regimen.

Clarithromycin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools, often transient. - Abdominal pain: cramping or discomfort. - Altered taste: metallic or bitter sensation.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or jaundice. - Cardiac arrhythmia: QT interval prolongation. - Severe allergic reactions: rash, angioedema, or anaphylaxis.

Before prescribing Klacid, consider patient‑specific factors and monitor for potential complications.

Renal or hepatic impairment: adjust therapy based on function. Drug‑induced QT prolongation: avoid in patients with known cardiac conduction disorders. Pregnancy and lactation: safety not established; weigh benefits against risks. Concomitant medications: assess for interactions that may affect clarithromycin levels. Store at ambient temperature: keep below 25 °C, retain original packaging, and protect from moisture.

Clarithromycin interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Statins (e.g., simvastatin, lovastatin): risk of rhabdomyolysis. - Certain antiarrhythmics (e.g., amiodarone): may cause severe bradycardia.

Moderate Interactions (Monitor Closely): - Warfarin: increased anticoagulant effect, monitor INR. - Theophylline: elevated plasma levels, watch for toxicity. - Oral contraceptives: reduced efficacy, consider alternative contraception.